Promoter hypermethylation of SOX11 correlates with adverse clinicopathological features of human prostate cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Promoter hypermethylation of SOX11
correlates with adverse clinicopathological features of human prostate cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Volume 98, Issue 6, Pages 341-346
Publisher
Wiley
Online
2018-01-10
DOI
10.1111/iep.12257
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology of Prostate Cancer
- (2015) Muhammad Naeem Bashir Asian Pacific Journal of Cancer Prevention
- SOX4 Is Essential for Prostate Tumorigenesis Initiated by PTEN Ablation
- (2015) B. Bilir et al. CANCER RESEARCH
- The role of tumor suppressor gene SOX11 in prostate cancer
- (2015) Zhiyong Yao et al. TUMOR BIOLOGY
- Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer
- (2015) Xiaoyang Xu et al. CELLULAR ONCOLOGY
- Hypermethylation of the GABRE miR-452 miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy
- (2014) H. Kristensen et al. CLINICAL CANCER RESEARCH
- Prognostic DNA Methylation Markers for Prostate Cancer
- (2014) Siri Strand et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Promoter methylation status of the tumor suppressor gene SOX11 is associated with cell growth and invasion in nasopharyngeal carcinoma
- (2013) Song Zhang et al. Cancer Cell International
- Transcription factor Sox11 is essential for both embryonic and adult neurogenesis
- (2013) Yong Wang et al. DEVELOPMENTAL DYNAMICS
- Association between RASSF1A Promoter Methylation and Prostate Cancer: A Systematic Review and Meta-Analysis
- (2013) Jincheng Pan et al. PLoS One
- Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma
- (2012) L. Nygren et al. BLOOD
- SOXs in human prostate cancer: implication as progression and prognosis factors
- (2012) Wei-de Zhong et al. BMC CANCER
- The SOX family of genes in cancer development: biological relevance and opportunities for therapy
- (2012) Sandra D Castillo et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation
- (2011) Sandra Sernbo et al. BMC CANCER
- SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies
- (2010) Elin Gustavsson et al. Molecular Cancer
- Sox11 Prevents Tumorigenesis of Glioma-Initiating Cells by Inducing Neuronal Differentiation
- (2009) T. Hide et al. CANCER RESEARCH
- SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
- (2009) A. Mozos et al. HAEMATOLOGICA
- Promoter Methylation in APC, RUNX3, and GSTP1 and Mortality in Prostate Cancer Patients
- (2009) Lorenzo Richiardi et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate Specific Antigen Best Practice Statement: 2009 Update
- (2009) Kirsten L. Greene et al. JOURNAL OF UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started